Leonabio Inc (LONA)

May 25, 2026

LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ReactionDebt Analysis Report - Newser

May 25, 2026

May 24, 2026

LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrower-Than-Expected Loss Buoyed by R&D ProgressCrowd Stock Picks - Newser

May 24, 2026

May 23, 2026

LeonaBio Inc. (LONA) Q1 2026 Earnings: Narrowing Losses Signal Operational DisciplineRetail Earnings Report - Newser

May 23, 2026

May 22, 2026

Why Is LeonaBio, Inc. (LONA) Stock Up Today? - Meyka

May 22, 2026

May 22, 2026

Why Is LeonaBio, Inc. (LONA) Stock Down Today? - Meyka

May 22, 2026

May 15, 2026

ADAR1, Daniel Schneeberger disclose 727,481 shares in LeonaBio (ATHA) - Stock Titan

May 15, 2026

May 11, 2026

LeonaBio (ATHA) details 2026 director, auditor and Say-on-Pay votes - Stock Titan

May 11, 2026

May 11, 2026

Mizuho Securities Maintains LeonaBio(LONA.US) With Buy Rating, Maintains Target Price $16 - Moomoo

May 11, 2026

May 10, 2026

Dividend HistoryLeonaBio, Inc. (LONA) - Zacks Investment Research

May 10, 2026

May 10, 2026

LONA: LeonaBio, Inc.Insider Transations - Zacks Investment Research

May 10, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 07, 2026

LeonaBio (LONA) director receives 56,000 stock options at $9.63 strike - Stock Titan

May 07, 2026

May 07, 2026

Director at LeonaBio (LONA) granted 56,000 stock options - Stock Titan

May 07, 2026

May 07, 2026

Option grant gives LeonaBio (LONA) director 56,000 shares at $9.63 - Stock Titan

May 07, 2026

May 07, 2026

Natalie Holles named LeonaBio (LONA) director in initial Form 3 - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio (LONA) director Peter B. Silverman files initial Form 3 - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio (LONA) director Callori Fred files baseline Form 3 ownership report - Stock Titan

May 07, 2026

May 07, 2026

Perceptive Advisors (ATHA) caps LeonaBio stake at 19.99% and gains board seat - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio (NASDAQ: ATHA) widens loss as R&D ramps for lasofoxifene and ALS drug - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio (NASDAQ: ATHA) widens Q1 loss while funding late-stage trials - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2026

May 07, 2026

LeonaBio reshapes board with 3 hires as long-serving director exits - Stock Titan

May 07, 2026

May 07, 2026

LeonaBio John Fluke Retires, Effective May 4 >LONA - Moomoo

May 07, 2026

May 07, 2026

LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. - Weekly Voice

May 07, 2026

May 07, 2026

LeonaBio Enhances Board of Directors with Appointments of - GlobeNewswire

May 07, 2026

May 06, 2026

LeonaBio, Inc. (LONA) Stock Forecast 2027, 2031 & 7-Year Price Prediction | Meyka AI - Meyka

May 06, 2026

May 06, 2026

How sustainable is LeonaBio (LONA) profit margins? (Selling Pressure) 2026-05-06Hot Market Picks - newser.com

May 06, 2026

Apr 27, 2026

LONA Earnings History & Surprises | EPS & Revenue Results | LEONABIO INC (NASDAQ:LONA) - ChartMill

Apr 27, 2026

Apr 24, 2026

LONA LeonaBio reports sharply worse than expected Q4 2025 EPS, shares drop 3.36% on investor disappointment.Sector Underperform - newser.com

Apr 24, 2026

Apr 23, 2026

Athira Pharma (LONA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $LONA - MarketBeat

Apr 23, 2026

Apr 23, 2026

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer - Yahoo Finance

Apr 23, 2026

Apr 23, 2026

LeonaBio to Host Virtual Key Opinion Leader Event - GlobeNewswire

Apr 23, 2026

Apr 21, 2026

LeonaBio (LONA) Showcases Lasofoxifene Research at AACR26 - GuruFocus

Apr 21, 2026

Apr 21, 2026

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data - The Manila Times

Apr 21, 2026

Apr 21, 2026

Independent Nonclinical Research on Lasofoxifene Presented - GlobeNewswire

Apr 21, 2026

Apr 20, 2026

LeonaBio (LONA) Stock: Is It Testing Levels (Overhead Buying) 2026-04-20Earnings Miss Stocks - Xã Thanh Hà

Apr 20, 2026

Apr 13, 2026

28,000-share stock option grant to LeonaBio (LONA) director - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) awards 300,000 stock options to chief scientific officer - Stock Titan

Apr 13, 2026

Apr 13, 2026

28,000 stock options granted to LeonaBio (LONA) director Kosacz - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) director Grant Pickering receives 28,000 stock options - Stock Titan

Apr 13, 2026

Apr 13, 2026

Director Romano Kelly receives 28,000 LeonaBio (LONA) stock options at $9.54 - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) director receives options to buy 28,000 shares at $9.54 - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) director awarded options on 28,000 shares at $9.54 - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) grants CMO 350,000 options at $9.54 - Stock Titan

Apr 13, 2026

Apr 13, 2026

Director John M. Fluke Jr. receives 28,000-share option grant at LeonaBio (LONA) - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) awards 300,000 stock options to general counsel - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) CFO awarded 300,000 stock options at $9.54 - Stock Titan

Apr 13, 2026

Apr 13, 2026

LeonaBio (LONA) CEO awarded 750,000 stock options at $9.54 strike - Stock Titan

Apr 13, 2026